Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3081.TWO Stock Summary
In the News
3081.TWO Financial details
Company Rating
Sell
Market Cap
12.73B
Income
-211.75M
Revenue
1.06B
Book val./share
42.28
Cash/share
14.26
Dividend
3.5
Dividend %
3.48%
Employees
353
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-144.44
Forward P/E
32.49
PEG
8.79
P/S
6.45
P/B
2.36
P/C
9.5
P/FCF
37.81
Quick Ratio
7.89
Current Ratio
9.74
Debt / Equity
0.08
LT Debt / Equity
0.08
-
-
EPS (TTM)
-2.32
EPS next Y
4.17
EPS next Q
-0.11
EPS this Y
-164.27%
EPS next Y
-279.88%
EPS next 5Y
-279.88%
EPS last 5Y
NAN%
Revenue last 5Y
-13.14%
Revenue Q/Q
65.74%
EPS Q/Q
-71.67%
-
-
-
-
SMA20
-8.61%
SMA50
33.98%
SMA100
36.63%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-2%
ROC
-0.02%
Gross Margin
22%
Oper. Margin
-7%
Profit Margin
-4%
Payout
-
Shs Outstand
91.62M
Shs Float
91.34M
-
-
-
-
Target Price
-
52W Range
88.5-165.5
52W High
-17.88%
52W Low
+53.98%
RSI
45
Rel Volume
0.22
Avg Volume
3.7M
Volume
827.35K
Perf Week
-3.21%
Perf Month
-1.09%
Perf Quarter
18.86%
Perf Half Y
17.32%
-
-
-
-
Beta
1.226
-
-
Volatility
2.37%, 8.18%
Prev Close
1.5%
Price
135.5
Change
0.74%
3081.TWO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 23.57 | 25.43 | 20.58 | 26.08 | 11.56 | |
Net income per share | 4.97 | 6.5 | 3.71 | 3.61 | -2.32 | |
Operating cash flow per share | 9.94 | 11.2 | 11.23 | 7 | 2.62 | |
Free cash flow per share | -2.62 | 6.54 | 8.96 | 3.02 | 0.97 | |
Cash per share | 14.82 | 17.07 | 19.49 | 18.03 | 14.26 | |
Book value per share | 44.87 | 47.89 | 46.94 | 47.73 | 42.28 | |
Tangible book value per share | 44.87 | 47.89 | 46.94 | 47.73 | 42.28 | |
Share holders equity per share | 44.87 | 47.89 | 46.94 | 47.73 | 42.28 | |
Interest debt per share | 3.59 | 3.63 | 3.54 | 3.48 | 3.41 | |
Market cap | 28.01B | 25.65B | 17.88B | 9.68B | 9.77B | |
Enterprise value | 26.99B | 24.43B | 16.43B | 8.35B | 9.5B | |
P/E ratio | 62.21 | 43.43 | 52.98 | 29.36 | -46.21 | |
Price to sales ratio | 13.11 | 11.11 | 9.55 | 4.06 | 9.25 | |
POCF ratio | 31.09 | 25.23 | 17.5 | 15.14 | 40.79 | |
PFCF ratio | -117.99 | 43.18 | 21.94 | 35.1 | 110.56 | |
P/B Ratio | 6.89 | 5.9 | 4.19 | 2.22 | 2.53 | |
PTB ratio | 6.89 | 5.9 | 4.19 | 2.22 | 2.53 | |
EV to sales | 12.63 | 10.58 | 8.77 | 3.51 | 8.99 | |
Enterprise value over EBITDA | 28.82 | 20.71 | 17.98 | 9.68 | 48.24 | |
EV to operating cash flow | 29.96 | 24.03 | 16.08 | 13.05 | 39.65 | |
EV to free cash flow | -113.69 | 41.13 | 20.16 | 30.27 | 107.45 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | -0.02 | |
Free cash flow yield | -0.01 | 0.02 | 0.05 | 0.03 | 0.01 | |
Debt to equity | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | |
Debt to assets | 0.07 | 0.06 | 0.06 | 0.06 | 0.07 | |
Net debt to EBITDA | -1.09 | -1.03 | -1.59 | -1.54 | -1.4 | |
Current ratio | 4.43 | 4.64 | 6.09 | 5.59 | 8.73 | |
Interest coverage | 124.57 | 176.56 | 100.39 | 80.31 | -50.92 | |
Income quality | 1.67 | 1.43 | 2.44 | 1.69 | -0.91 | |
Dividend Yield | 0.02 | 0.01 | 0.03 | 0.03 | 0.03 | |
Payout ratio | 1.01 | 0.62 | 1.35 | 0.97 | -1.52 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.06 | 0.05 | 0.09 | |
Research and developement to revenue | 0.15 | 0.12 | 0.11 | 0.11 | 0.28 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.26 | -0.42 | -0.2 | -0.57 | -0.63 | |
Capex to revenue | -0.53 | -0.18 | -0.11 | -0.15 | -0.14 | |
Capex to depreciation | -2.89 | -0.91 | -0.42 | -0.76 | -0.33 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham number | 70.81 | 83.72 | 62.59 | 62.26 | 46.94 | |
ROIC | 0.1 | 0.12 | 0.07 | 0.07 | -0.05 | |
Return on tangible assets | 0.09 | 0.11 | 0.07 | 0.06 | -0.05 | |
Graham Net | 11.08 | 14.26 | 15.86 | 15.67 | 12.49 | |
Working capital | 1.54B | 1.89B | 1.99B | 2.06B | 1.69B | |
Tangible asset value | 4.06B | 4.34B | 4.27B | 4.35B | 3.86B | |
Net current asset value | 1.22B | 1.57B | 1.67B | 1.75B | 1.39B | |
Invested capital | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | |
Average receivables | 469.78M | 541.03M | 477.49M | 393.51M | 359.34M | |
Average payables | 73.36M | 100.51M | 99.84M | 132.75M | 116.09M | |
Average inventory | 221.73M | 200.28M | 248.75M | 332.81M | 366.72M | |
Days sales outstanding | 74.91 | 101.74 | 60.68 | 72.92 | 83.99 | |
Days payables outstanding | 29.81 | 35.22 | 29.5 | 39.67 | 22.24 | |
Days of inventory on hand | 63.37 | 66.34 | 95.68 | 84.65 | 142.07 | |
Receivables turnover | 4.87 | 3.59 | 6.01 | 5.01 | 4.35 | |
Payables turnover | 12.24 | 10.36 | 12.37 | 9.2 | 16.41 | |
Inventory turnover | 5.76 | 5.5 | 3.81 | 4.31 | 2.57 | |
ROE | 0.11 | 0.14 | 0.08 | 0.08 | -0.05 | |
Capex per share | -12.56 | -4.66 | -2.27 | -3.98 | -1.66 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.32 | 3.58 | 2.78 | 1.96 | 3.25 | |
Net income per share | 1.28 | -0.33 | -0.45 | -1.2 | -0.34 | |
Operating cash flow per share | 2.78 | 1.49 | 0.24 | 0.06 | 0.83 | |
Free cash flow per share | 2.37 | 0.68 | -0.31 | -0.09 | 0.68 | |
Cash per share | 18.02 | 18.68 | 18.48 | 13.66 | 14.26 | |
Book value per share | 47.68 | 43.9 | 43.79 | 42.58 | 42.28 | |
Tangible book value per share | 47.68 | 43.9 | 43.79 | 42.58 | 42.28 | |
Share holders equity per share | 47.68 | 43.9 | 43.79 | 42.58 | 42.28 | |
Interest debt per share | 3.44 | 3.42 | 3.42 | 3.38 | 3.36 | |
Market cap | 9.68B | 12.11B | 9.26B | 11.51B | 9.77B | |
Enterprise value | 8.35B | 11.72B | 8.66B | 11.28B | 9.5B | |
P/E ratio | 20.64 | -99.52 | -56.67 | -26.25 | -79.15 | |
Price to sales ratio | 14.49 | 36.97 | 36.64 | 64.27 | 32.93 | |
POCF ratio | 38.12 | 88.73 | 417.5 | 2.2K | 129.08 | |
PFCF ratio | 44.66 | 194.15 | -332.58 | -1.47K | 158.37 | |
P/B Ratio | 2.22 | 3.02 | 2.33 | 2.96 | 2.53 | |
PTB ratio | 2.22 | 3.02 | 2.33 | 2.96 | 2.53 | |
EV to sales | 12.5 | 35.8 | 34.23 | 63 | 32.01 | |
Enterprise value over EBITDA | 35.2 | 143.02 | 156.56 | -576.48 | 119.92 | |
EV to operating cash flow | 32.88 | 85.92 | 390.13 | 2.15K | 125.46 | |
EV to free cash flow | 38.53 | 187.98 | -310.77 | -1.44K | 153.91 | |
Earnings yield | 0.01 | 0 | 0 | -0.01 | 0 | |
Free cash flow yield | 0.02 | 0.01 | 0 | 0 | 0.01 | |
Debt to equity | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | |
Debt to assets | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | |
Net debt to EBITDA | -5.6 | -4.69 | -10.98 | 11.66 | -3.47 | |
Current ratio | 5.59 | 3.82 | 4.22 | 9.74 | 8.73 | |
Interest coverage | 94.19 | -22.17 | -45.2 | -106.55 | -30.1 | |
Income quality | 2.1 | -4.52 | -0.38 | -0.04 | -1.96 | |
Dividend Yield | 0 | 0 | 0 | 0.03 | 0 | |
Payout ratio | 0 | 0 | 0 | -2.93 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.06 | 0.1 | 0.13 | 0.07 | |
Research and developement to revenue | 0.11 | 0.18 | 0.3 | 0.45 | 0.25 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.15 | -0.54 | -2.26 | -2.49 | -0.18 | |
Capex to revenue | -0.06 | -0.23 | -0.2 | -0.07 | -0.05 | |
Capex to depreciation | -0.32 | -0.67 | -0.44 | -0.11 | -0.12 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | |
Graham number | 37.12 | 18.13 | 21.06 | 33.9 | 17.93 | |
ROIC | 0.02 | -0.01 | -0.01 | -0.02 | -0.01 | |
Return on tangible assets | 0.02 | -0.01 | -0.01 | -0.03 | -0.01 | |
Graham Net | 15.65 | 12.66 | 13.22 | 11.87 | 12.49 | |
Working capital | 2.06B | 1.73B | 1.75B | 1.62B | 1.69B | |
Tangible asset value | 4.35B | 4.01B | 3.97B | 3.88B | 3.86B | |
Net current asset value | 1.75B | 1.42B | 1.44B | 1.31B | 1.39B | |
Invested capital | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | |
Average receivables | 496.96M | 364.27M | 259.54M | 239.96M | 228.35M | |
Average payables | 194.57M | 107.59M | 43.76M | 44.21M | 47.88M | |
Average inventory | 363.25M | 369.59M | 355.55M | 341.58M | 346.19M | |
Days sales outstanding | 64.04 | 69.5 | 94.77 | 107.42 | 73.7 | |
Days payables outstanding | 37.73 | 12.95 | 20.32 | 16.74 | 23.08 | |
Days of inventory on hand | 80.52 | 120.78 | 145.53 | 140.87 | 147.45 | |
Receivables turnover | 1.41 | 1.29 | 0.95 | 0.84 | 1.22 | |
Payables turnover | 2.39 | 6.95 | 4.43 | 5.37 | 3.9 | |
Inventory turnover | 1.12 | 0.75 | 0.62 | 0.64 | 0.61 | |
ROE | 0.03 | -0.01 | -0.01 | -0.03 | -0.01 | |
Capex per share | -0.41 | -0.81 | -0.55 | -0.14 | -0.15 |
3081.TWO Frequently Asked Questions
What is LandMark Optoelectronics Corporation stock symbol ?
LandMark Optoelectronics Corporation is a TW stock and trading under the symbol 3081.TWO
What is LandMark Optoelectronics Corporation stock quote today ?
LandMark Optoelectronics Corporation stock price is $135.5 today.
Is LandMark Optoelectronics Corporation stock public?
Yes, LandMark Optoelectronics Corporation is a publicly traded company.